These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20403008)

  • 21. Economic evaluation of relapse prevention for substance users: treatment settings and health care policy.
    Yamada T; Chen CC; Yamada T
    Adv Health Econ Health Serv Res; 2005; 16():431-50. PubMed ID: 17867251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating petrol-sniffing prevention programs.
    Mobbs R
    Aust J Public Health; 1993 Mar; 17(1):79-80. PubMed ID: 8357904
    [No Abstract]   [Full Text] [Related]  

  • 23. Testing theory through developmental epidemiologically based prevention research.
    Kellam SG
    NIDA Res Monogr; 1994; 139():37-57. PubMed ID: 8742550
    [No Abstract]   [Full Text] [Related]  

  • 24. Methodological issues in prevention research on drug use and pregnancy.
    Gilchrist LD; Gillmore MR
    NIDA Res Monogr; 1992; 117():1-17. PubMed ID: 1620189
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug prevention research with Hispanic populations: theoretical and methodological issues and a generic structural model.
    Castro FG; Harmon MP; Coe K; Tafoya-Barraza HM
    NIDA Res Monogr; 1994; 139():203-33. PubMed ID: 8742558
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug prevention program results found to be modest, slow.
    Health Care Financ Rev; 1999; 21(1):138-9. PubMed ID: 11481732
    [No Abstract]   [Full Text] [Related]  

  • 27. Use and misuse of repeated measures designs.
    Barcikowski RS; Robey RR
    NIDA Res Monogr; 1994; 142():302-41. PubMed ID: 9243540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Publication bias: a concern just for drug prevention or for the entire drug control literature?
    Caulkins JP
    Drug Alcohol Rev; 2008 Jul; 27(4):345-6; discussion 352-6. PubMed ID: 18584378
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug abuse prevention evaluation methodology: a bright future.
    Leukefeld CG; Bukoski WJ
    J Drug Educ; 1991; 21(3):191-201. PubMed ID: 1919958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An example of international drug politics--the development and distribution of substance prevention programs directed at adolescents.
    Lilja J; Giota J; Hamilton D; Larsson S
    Subst Use Misuse; 2007; 42(2-3):317-42. PubMed ID: 17558933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How all stars works: an examination of program effects on mediating variables.
    McNeal RB; Hansen WB; Harrington NG; Giles SM
    Health Educ Behav; 2004 Apr; 31(2):165-78. PubMed ID: 15090119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of mediating variables in prevention and intervention research.
    MacKinnon DP
    NIDA Res Monogr; 1994; 139():127-53. PubMed ID: 8742555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fidelity of implementation in a treatment effectiveness trial of Reconnecting Youth.
    Sánchez V; Steckler A; Nitirat P; Hallfors D; Cho H; Brodish P
    Health Educ Res; 2007 Feb; 22(1):95-107. PubMed ID: 16807378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion of drug abuse prevention programs: spontaneous diffusion, agenda setting, and reinvention.
    Rogers EM
    NIDA Res Monogr; 1995; 155():90-105. PubMed ID: 8594465
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of objectives and implementation of services of a combined program for prevention and health promotion].
    Desjardins N; Kishchuk N; Lamoureux MC
    Can J Commun Ment Health; 1994; 13(2):145-61. PubMed ID: 10172304
    [No Abstract]   [Full Text] [Related]  

  • 36. Application of case management to drug abuse treatment: overview of models and research issues.
    Ridgely MS; Willenbring ML
    NIDA Res Monogr; 1992; 127():12-33. PubMed ID: 1435992
    [No Abstract]   [Full Text] [Related]  

  • 37. A six-community prevention trial to reduce alcohol and drug use-related problems in Sweden: planning and early findings.
    Andréasson S; Sjöström E; Bränström R
    Subst Use Misuse; 2007; 42(12-13):2017-27. PubMed ID: 18075925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothesis testing and the EU-Dap evaluation of the Unplugged curriculum.
    Gorman DM
    Prev Med; 2009 Jun; 48(6):604-5; author reply 606-7. PubMed ID: 19168091
    [No Abstract]   [Full Text] [Related]  

  • 39. Addressing the wider determinants of problematic drug use: advantages of whole-population over targeted interventions.
    Bonell C; Fletcher A
    Int J Drug Policy; 2008 Aug; 19(4):267-9. PubMed ID: 18032013
    [No Abstract]   [Full Text] [Related]  

  • 40. Output or impact: what should we be evaluating in research programs?
    Scanes CG
    Poult Sci; 2009 Nov; 88(11):2243. PubMed ID: 19834071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.